Clinical Development of the E75 Vaccine in Breast Cancer.
2016
E75 is an immunogenic peptide derived from the human epidermal growth factor receptor 2 (HER2) protein. A large amount of preclinical work evaluated the immunogenicity of E75, after which phase I tria
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
55
References
22
Citations
NaN
KQI